Multiomics integration prioritizes potential drug targets for multiple sclerosis. Jiang Y, Liu Q, Stridh P, Kockum I, et al. Proc Natl Acad Sci U S A 2025;122:e2425537122.

Read + Share

Amedeo Smart

Independent Medical Education

Jiang Y, Liu Q, Stridh P, Kockum I, et al. Multiomics integration prioritizes potential drug targets for multiple sclerosis. Proc Natl Acad Sci U S A 2025;122:e2425537122.
PMID: 40577117